Results 141 to 150 of about 5,463 (188)

Phase II Trial of nab-Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. [PDF]

open access: yesJ Clin Oncol
Wagner AJ   +14 more
europepmc   +1 more source

Analysis of resurgeries following primary glaucoma surgical intervention in a tertiary care center. [PDF]

open access: yesIndian J Ophthalmol
Sharmila R   +4 more
europepmc   +1 more source

AANDERAA RCM documentation [PDF]

open access: yes, 2017
AANDERAA Instruments, N.N.
core  

Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma. [PDF]

open access: yesJ Immunother Cancer
Movva S   +27 more
europepmc   +1 more source

Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial. [PDF]

open access: yesNat Commun
Jones RL   +10 more
europepmc   +1 more source

Pemigatinib for previously treated metastatic or unresectable central nervous system tumors with fibroblast growth factor receptor mutations or rearrangements: FIGHT-207 results. [PDF]

open access: yesOncologist
Spanggaard I   +12 more
europepmc   +1 more source

Four Neotropical frog species exhibit shared and distinct skin bacterial communities in a laboratory setting. [PDF]

open access: yesMicroPubl Biol
Jansari V   +31 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy